Canaccord Genuity Analysts Give Health Insurance Innovations, Inc. (HIIQ) a $39.00 Price Target

Canaccord Genuity set a $39.00 price target on Health Insurance Innovations, Inc. (NASDAQ:HIIQ) in a research report sent to investors on Sunday morning. The firm currently has a buy rating on the financial services provider’s stock.

Several other research firms also recently issued reports on HIIQ. Cantor Fitzgerald reiterated an overweight rating and issued a $38.00 price objective on shares of Health Insurance Innovations in a report on Tuesday, September 12th. ValuEngine upgraded Health Insurance Innovations from a buy rating to a strong-buy rating in a report on Monday, October 2nd. Zacks Investment Research upgraded Health Insurance Innovations from a hold rating to a buy rating and set a $33.00 price objective on the stock in a report on Friday, August 4th. Craig Hallum reiterated a buy rating and issued a $38.00 price objective (up previously from $28.00) on shares of Health Insurance Innovations in a report on Thursday, August 3rd. Finally, TheStreet downgraded Health Insurance Innovations from a b- rating to a c rating in a report on Thursday, September 28th. One research analyst has rated the stock with a hold rating, seven have issued a buy rating and two have assigned a strong buy rating to the company. The company presently has a consensus rating of Buy and a consensus price target of $30.86.

Shares of Health Insurance Innovations (NASDAQ HIIQ) opened at $24.25 on Friday. Health Insurance Innovations has a 1 year low of $8.30 and a 1 year high of $37.38. The company has a market capitalization of $402.77, a price-to-earnings ratio of 16.57 and a beta of 0.63.

Health Insurance Innovations (NASDAQ:HIIQ) last posted its earnings results on Wednesday, November 1st. The financial services provider reported $0.46 EPS for the quarter, beating the Zacks’ consensus estimate of $0.35 by $0.11. Health Insurance Innovations had a return on equity of 21.32% and a net margin of 5.98%. The company had revenue of $63.34 million for the quarter, compared to the consensus estimate of $59.30 million. During the same quarter in the previous year, the business earned $0.33 earnings per share. The company’s revenue for the quarter was up 37.4% on a year-over-year basis. analysts forecast that Health Insurance Innovations will post 1.65 earnings per share for the current fiscal year.

TRADEMARK VIOLATION NOTICE: This story was first published by Stock Observer and is the property of of Stock Observer. If you are accessing this story on another publication, it was stolen and reposted in violation of international copyright & trademark laws. The correct version of this story can be viewed at https://www.thestockobserver.com/2017/11/15/canaccord-genuity-analysts-give-health-insurance-innovations-inc-hiiq-a-39-00-price-target.html.

Health Insurance Innovations declared that its board has approved a stock buyback program on Monday, October 16th that authorizes the company to buyback $50.00 million in shares. This buyback authorization authorizes the financial services provider to repurchase shares of its stock through open market purchases. Shares buyback programs are generally a sign that the company’s board of directors believes its stock is undervalued.

In related news, CEO of HealthPocket Bruce Telkamp sold 9,970 shares of the business’s stock in a transaction on Friday, September 1st. The stock was sold at an average price of $36.19, for a total transaction of $360,814.30. Following the completion of the transaction, the insider now directly owns 19,500 shares of the company’s stock, valued at approximately $705,705. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Robert S. Murley bought 3,000 shares of the stock in a transaction that occurred on Friday, September 1st. The shares were bought at an average cost of $30.21 per share, with a total value of $90,630.00. Following the completion of the purchase, the director now directly owns 34,734 shares in the company, valued at $1,049,314.14. The disclosure for this purchase can be found here. Insiders have sold a total of 48,576 shares of company stock valued at $1,584,152 over the last three months. 30.00% of the stock is currently owned by insiders.

A number of institutional investors and hedge funds have recently added to or reduced their stakes in the stock. Cubist Systematic Strategies LLC acquired a new position in Health Insurance Innovations during the 3rd quarter worth $368,000. Tenzing Global Management LLC acquired a new position in Health Insurance Innovations during the 3rd quarter worth $1,015,000. Lyon Street Capital LLC grew its stake in Health Insurance Innovations by 49.4% during the 3rd quarter. Lyon Street Capital LLC now owns 936,747 shares of the financial services provider’s stock worth $13,583,000 after purchasing an additional 309,668 shares in the last quarter. B. Riley Financial Inc. grew its stake in Health Insurance Innovations by 62.0% during the 3rd quarter. B. Riley Financial Inc. now owns 405,000 shares of the financial services provider’s stock worth $5,873,000 after purchasing an additional 155,000 shares in the last quarter. Finally, Engineers Gate Manager LP acquired a new position in Health Insurance Innovations during the 3rd quarter worth $1,879,000. 62.42% of the stock is owned by hedge funds and other institutional investors.

About Health Insurance Innovations

Health Insurance Innovations, Inc is a developer, distributor and cloud-based administrator of individual and family health insurance plans (IFPs) and supplemental products, which include short-term medical (STM) insurance plans, and guaranteed-issue and underwritten hospital indemnity plans. The Company also develops, distributes and administers supplemental products, which include a range of additional insurance and non-insurance products, such as pharmacy benefit cards, dental plans, vision plans, cancer/critical illness plans, deductible and gap protection plans, and life insurance policies that are purchased as supplements to IFP.

Analyst Recommendations for Health Insurance Innovations (NASDAQ:HIIQ)

Receive News & Ratings for Health Insurance Innovations Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Health Insurance Innovations Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply